Biliary atresia: lessons learned from the voluntary German registry

Area of Science:

• Pediatric Hepatology
• Gastroenterology
• Public Health

Background:

• Biliary atresia (BA) is a rare neonatal liver disease requiring specialized management.
• Current voluntary registries may not capture all affected patients, hindering comprehensive data collection.
• Assessing the feasibility of registries and healthcare system organization is vital for improving patient outcomes.

Purpose of the Study:

• To conduct a 5-year survey of biliary atresia (BA) patients in Germany.
• To evaluate the completeness of the European Biliary Atresia Registry (EBAR) for German patients.
• To discuss the feasibility of voluntary registries and propose improvements for BA patient management.

Main Methods:

• Retrospective analysis of German BA patients born between 2001-2005.
• Data from the voluntary European Biliary Atresia Registry (EBAR) and non-registered liver transplant patients were combined.
• Kaplan-Meier survival analysis and Cox regression were used to assess factors influencing survival.

Main Results:

• 11% of EBAR charts were misdiagnosed; 25% of German BA patients were not registered in EBAR.
• 29 hospitals performed Kasai procedures, with only 7 centers treating over 5 patients.
• Center experience was the only significant predictor of jaundice-free survival with native liver (p=0.001).

Conclusions:

• A significant portion of German BA patients remain outside existing registries.
• Decentralized, internet-based registries are proposed to improve data collection for rare neonatal liver diseases.
• Centralizing BA patient care at high-volume, experienced centers is recommended to enhance treatment outcomes.